论文部分内容阅读
一些典有抗瘤效应的非千拢紊性调节剂在最近一次国际癌症会议上,许多生物反应调节剂受到重视,其中包括;C 反应蛋白.葡萄球菌蛋白A,来自于1gG 的多肽链——tugtsin,可以逆转转化的transrecers 和日本食用蘑菇中提取的一种多糖——lentinan 等.C 反应蛋白是机体在急性炎症反应时产生的一种蛋白质,已发现50年,但其功能尚不明.Deodhar 博士证明它可激活巨噬细胞而增强机体抵抗力,将C 反应蛋白装入脂微粒中,用于动物癌症模型,发现可防治癌症的转移.目前正在多种动物模型中试用,一旦成功,将进一步进行临床试验.Deodbar 博士认为骨肉瘤首选适用此种试剂治疗,乳癌和结肠癌亦可一试.
Some non-controversial modulators with typical anti-tumor effects At the most recent International Conference on Cancer, many biological response modifiers were highlighted, including; C-reactive protein, staphylococcal protein A, a polypeptide chain derived from 1gG - Tugtsin can reverse the transformed transrecers and a polysaccharide extracted from Japanese edible mushrooms—lentinan, etc. The C-reactive protein is a protein produced by the body during acute inflammation, and has been found for 50 years, but its function is still unknown. Dr. Ph.D. proved that it activates macrophages and enhances body resistance. C-reactive protein is loaded into lipid particles and used in animal cancer models to detect cancer metastasis. It is currently being tested in a variety of animal models. Once successful, it will Further clinical trials. Dr. Deodbar believes that osteosarcoma is the first choice for this type of treatment. Breast cancer and colon cancer can also be tested.